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CYP154C5, a bacterial cytochrome P450
Paula Bracco1, Dick B Janssen2 and Anett Schallmey1*Abstract
Background: Cytochrome P450 monooxygenases – able to regio- and stereoselectively hydroxylate non-activated
carbon atoms – are important enzymes for the synthesis of valuable intermediates in the production of steroid
hormones in the pharmaceutical industry. However, up to now only a few bacterial enzymes able to hydroxylate
steroids have been reported. CYP154C5 from Nocardia farcinica IFM 10152, a bacterial P450 monooxygenase, was
previously shown to convert testosterone to 16α-hydroxytestosterone. Since the hydroxylation at 16α-position is of
special interest for the pharmaceutical industry, we have studied this enzyme in more detail to investigate its
activity and selectivity in bioconversions of further steroids.
Results: CYP154C5 was coexpressed in Escherichia coli together with putidaredoxin and putidaredoxin reductase
from Pseudomonas putida as redox partners for electron transfer and applied in bioconversions of various
pregnanes and androstanes [pregnenolone (1), dehydroepiandrosterone (2), progesterone (3), androstenedione (4),
testosterone (5) and nandrolone (6)]. Structure elucidation of the formed products revealed an exclusive regio- and
stereoselectivity of CYP154C5, always yielding the corresponding 16α-hydroxylated steroids. Application of whole
cells expressing the three components, P450, Pdx and PdR, in steroid biotransformations resulted in significantly
higher conversions and total turnover numbers (TTN) compared to reactions using cell-free extracts. Additionally,
considerably higher substrate loads (up to 15 mM) were tolerated by the whole-cell system. Furthermore, turnover
numbers (TON) were determined for the six different steroids using whole cells. Thus, testosterone was found to be
the worst substrate with a TON of only 0.8 μmol substrate consumed min-1 μmol-1 CYP154C5, while progesterone
and pregnenolone were converted the fastest resulting in TON of 3.3 μmol substrate consumed min-1 μmol-1
CYP154C5.
Conclusion: CYP154C5 from N. farcinica constitutes a promising catalyst due to its high regio- and stereoselectivity
in the hydroxylation of different steroids as well as its efficient expression in E. coli at high yields. Using this enzyme,
16α-hydroxylated steroids, which are important precursors for the synthesis of high value steroidal drugs in the
pharmaceutical industry, can be selectively produced on preparative scale with TTN (μmol substrate consumed
μmol-1 CYP154C5) exceeding 2000.
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Cytochrome P450 enzymes (CYPs) form a huge super-
family of heme-containing monooxygenases present in
all domains of life, where they play important roles in
the detoxification of xenobiotics, drug metabolism, the
assimilation of carbon sources and the formation of
secondary metabolites [1]. They catalyze a number of
chemically diverse reactions like hydroxylations, epoxi-
dations, dealkylations and dehalogenations [2,3], making
them very attractive catalysts for application in the syn-
thesis of fine chemicals and pharmaceuticals. In this re-
spect, the most important reaction is the selective
oxidation of (unactivated) C-H bonds using molecular
oxygen. Thus, P450 monooxygenases are applied in the
pharmaceutical industry for the regio- and stereoselect-
ive hydroxylation of steroid compounds – a reaction that
can be hardly achieved by chemical methods – to form
highly valuable steroid hormones like glucocorticoids,
mineralocorticoids and sexual hormones [2,4].
Because of their natural role in steroid synthesis, today a
lot more eukaryotic CYPs (mainly mammalian enzymes)
capable of steroid hydroxylation are known compared to
prokaryotic ones. However, the biotechnological use of
eukaryotic P450 monooxygenases is significantly ham-
pered by the fact that they are membrane bound within
the cells [5], and often show low catalytic activities. In
contrast, bacterial CYPs are soluble enzymes that
usually can be overexpressed to very high amounts
allowing much higher productivities in biotransforma-
tions. Nevertheless, only a very limited number of
known bacterial cytochrome P450 monooxygenases are
able to perform selective steroid hydroxylations [6].
Despite the fact that a large number of bacterial species
are reported in literature to carry out hydroxylation of
various steroids [7-10], the genes coding for the re-
spective CYPs are in most cases not known and the en-
zymes usually have been only poorly characterized. In
a recent study, Agematu et al. examined a library
consisting of 213 different bacterial CYPs for their abil-
ity to convert testosterone [11]. Of these 213 enzymes
only 24 turned out to be active on this steroid substrate,
exhibiting also different regio- and stereoselectivities. One
of these active P450 monooxygenases is CYP154C5 from
Nocardia farcinica IFM 10152. Agematu et al. reported
that this enzyme was able to convert 100 μM testosterone
(5) selectively into 16α-hydroxytestosterone (11) using
whole cell catalysis with an overall conversion >10% [11].
N. farcinica is a human pathogen causing a disease called
nocardiosis by infection of lung, central nervous sys-
tem, brain and cutaneous tissues. The bacterium be-
longs to the phylum of Actinobacteria and is naturally
found in soils. The genome sequence of N. farcinica
IFM 10152 was recently determined revealing the pres-
ence of 21 genes coding for putative cytochrome P450monooxygenases, of which two were shown to hydrox-
ylate steroids [12]. One of them is CYP154C5, a multi-
component P450 monooxygenase. For its activity, the
enzyme needs additional electron transfer components
delivering electrons from the cofactor NAD(P)H to the
heme of the monooxygenase. Since the natural electron
transfer partners of CYP154C5 are not known, electron
transfer components of other CYP systems have to be
used as substitutes. Thus it was shown before that
putidaredoxin (Pdx) and putidaredoxin reductase (PdR)
from the P450cam system of Pseudomonas putida
[11,13] as well as the reductase domain of P450RhF
(CYP116B2) from Rhodococcus sp. NCIMB 9784 [14]
can be applied as surrogate electron transfer partners
required for CYP154C5 activity.
Steroids are structurally derived from the four-ring
system sterane and vary in the presence of functional
groups and the oxidation state of the rings. The type,
number and position of functional groups in the steroid
backbone directly influence the physiological activity
(such as the control of distinct aspects of cell prolifera-
tion, tissue differentiation and quorum sensing) [8].
Therefore, the regio- and stereoselective introduction of
functional groups, such as hydroxylations, is important
for the bioactivity of steroid drugs in a wide range of
therapeutic applications, namely as anti-inflammatory,
immunosuppressive, progestational, diuretic, anabolic or
contraceptive agents. Today, about 300 approved steroid
drugs are known and they represent the second largest
category of marketed medical products next to antibi-
otics [8]. Current studies on microbial steroid hydroxyl-
ation involve the search for novel biocatalysts capable of
performing oxyfunctionalizations at positions 7α, 9α,
11α, 11β, 16α and 17α [7,8,15]. Oxyfunctionalization at
position 11β is important for anti-inflammatory steroid
drugs such as cortisol, whereas 16α-hydroxylated ste-
roids are important intermediates in the synthesis of
highly active glucocorticoids [4]. Thus, the identification,
cloning and biocatalytic characterization of bacterial
cytochrome P450 monooxygenases able to hydroxylate
steroids of different structure at the specified positions
in a highly regio- and stereoselective fashion is of high
importance for the pharmaceutical industry. Further-
more, a detailed analysis of optimal reaction parameters
is crucial in order to develop efficient processes for the
large-scale production of hydroxylated steroids using
cytochrome P450s.
Based on the initial findings of Agematu et al., we herein
report the characterization and catalytic potential of
CYP154C5 from Nocardia farcinica IFM 10152 for its ap-
plication in regio- and stereoselective steroid hydroxylations
as well as the optimization and up-scaling of respective
biocatalytic reactions using different androstanes and
pregnanes as substrates.
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Cloning and recombinant expression of CYP154C5
The gene of CYP154C5 was amplified from vector
pKNL031_M17 from a genomic library of N. farcinica
IFM 10152 [12] using PCR and cloned into the broad
host-range vector pIT2-MCS [16]. Putidaredoxin and
putidaredoxin reductase from P. putida DSM50198 served
as electron transfer components in bioconversions [13].
For efficient coexpression of all three proteins in one host,
E. coli C43(DE3) - a mutant of E. coli BL21(DE3) - was
used [17]. Employing E. coli as a host for P450 expression
and biocatalysis offers the advantage that E. coli naturally
does not contain any endogenous P450 enzyme which
could result in background activity. Protein expression
was induced by IPTG addition and δ-aminolevulinic acid
was added for enhanced heme synthesis. Additionally,
trace element solution was used to supplement the media
especially with iron. Protein production at 10 L fermentor
scale with controlled oxygen supply and pH resulted in a
higher expression level compared to shake flasks (0.5 L).
In particular, expression of the redox partners Pdx and
PdR was more efficient. The obtained specific activity of
the electron transfer components (ETC activity) was in
the range of 1.1 to 1.4 U/mg total soluble protein at fer-
mentor scale in comparison to only 0.6 to 0.8 U/mg
obtained in shake flasks. With regard to P450 expression,
approximately 2.4 mg of CYP154C5 per g of wet cells
(corresponding to 45 mg CYP154C5 per liter culture and
1.7% CYP154C5 of total soluble protein) were produced
during 24 h cultivation in the fermentor.
Steroid conversions on analytical scale: whole cells versus
cell-free extract
In order to identify optimal reaction conditions for ster-
oid transformations using CYP154C5, bioconversions
employing resting whole cells (WC) or cell-free extract
(CFE) of E. coli C43(DE3) (pIT2cyp154C5) (pACYCcamAB)
were compared. Additionally, the influence of increas-
ing concentrations of steroid substrate (0.5 to 8 mM
for substrates 1, 2, 5 and 6; 0.5 to 15 mM for substrates
3 and 4) was investigated. In the whole-cell system an
OD600 of 40 was used, which is equivalent to 3 μM
CYP154C5 and an ETC activity of 9 U/mL (corre-
sponding to a specific activity of 1.4 U/mg) as deter-
mined by analysis of cell-free extract that was obtained
after cell disruption. In the case of bioconversions
using CFE 3 μM P450 and 6 U/mL (0.8 U/mg total pro-
tein) ETC activity were employed. Since the three
proteins were coexpressed in one host (for the whole-
cell biocatalyst as well as the CFE), only the level of one
of them was kept constant in the biocatalytic reactions
(3 μM CYP154C5 in this case). In bioconversions
using CFE efficient regeneration of the required cofac-
tor NADH was realized by addition of a cofactorregeneration system consisting of formate dehydrogen-
ase from Candida boidinii and sodium formate. In con-
trast, glucose was added for NADH regeneration within
the E. coli metabolism in case of whole-cell reactions.
As controls, either whole cells or CFE of E. coli C43
(DE3) (pACYCcamAB), not expressing the cytochrome
P450, were employed in steroid biotransformations.
Steroid conversions were determined by GC or HPLC
based on substrate depletion and total turnover num-
bers (TTN, μmol of substrate consumed per μmol of
CYP154C5 present in the reaction mixture) were calcu-
lated. For all tested substrates application of whole cells
resulted in higher conversions and higher TTN than
cell-free extract (Figure 1, see Additional file 1: Figure
S2 for substrates 2, 4 and 6). In all cases, except for tes-
tosterone (5), the difference in conversion and TTN be-
tween whole cells and CFE increases with increasing
substrate concentration. Hence, the whole-cell biocata-
lytic system is especially more suitable for reactions
with high initial steroid concentration. Highest TTN
were obtained for progesterone (3, TTN = 2440) and
androstenedione (4, TTN = 3341) for 10 and 15 mM
substrate concentration, respectively, using whole cells.
In contrast, TTN in steroid transformations using CFE
hardly exceeded 1000. However, it has to be stressed
that despite the high TTN full substrate conversion was
not achieved within 20 h reaction time using high ini-
tial substrate concentrations (≥ 8 mM). In control reac-
tions with E. coli C43(DE3) (pACYCcamAB) not
expressing CYP154C5 no product formation was ob-
served (Additional file 1: Figure S1).
Comparing reactions of the different substrates using
whole cells, it becomes obvious that 1, 2, 3 and 4 are
still fully converted for initial steroid concentrations of
up to 4 mM, whereas conversions obtained for sub-
strates 5 and 6 are already significantly reduced at sub-
strate concentrations above 0.5 mM. Hence, achieved
TTN for 5 and 6 are also significantly lower as com-
pared to steroids 1–4. Additionally, the influence of cell
density on the performance of the whole-cell biocata-
lytic reactions was investigated. For that, E. coli cells
containing CYP154C5, Pdx and PdR were resuspended
to obtain OD600 of 20, 30, 40 and 60 and tested in bio-
conversions with up to 8 mM 1, 3 and 5. For all sub-
strates, an optical density of 40 yielded the highest
conversions (data not shown). Other than expected,
product formation was not further increased in whole-
cell reactions with OD600 of 60. This might be attrib-
uted to an insufficient oxygen input and distribution in
reactions with high cell mass since oxygen availability
plays an important role in monooxygenase-catalyzed
reactions [18].
While resting cells proved to be superior to CFE bio-
conversions if comparable P450 concentrations were
Figure 1 Steroid bioconversions by whole cells (WC) and cell-free extract (CFE) of E. coli C43(DE3) (pIT2cyp154C5) (pACYCcamAB)
employing each 3 μM CYP154C5. Results are given as conversions (%) and total turnover numbers (TTN, μmol of substrate consumed per μmol
of CYP154C5 present in the reaction mixture) obtained in biotransformations of pregnenolone (1), progesterone (3) and testosterone (5) using
different initial substrate concentrations. All reactions were carried out in 50 mM potassium phosphate buffer pH 7.4 at 30°C for 20 h. Substrates
were added from stock solutions in 36% w/v hydroxypropyl-β-cyclodextrin in water. For cofactor regeneration in reactions using CFE, 0.5 U/mL
formate dehydrogenase from Candida boidinii and 150 mM sodium formate were employed. In reactions using whole cells cofactor regeneration
was achieved by addition of 30 mM glucose.
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in reactions with CFE was also investigated. Thus, CFE
conversions with different P450 concentrations were
performed for progesterone (3) and testosterone (5) using
also different substrate concentrations (from 0.5 to
8 mM). For this, concentrated CFE was diluted with differ-
ent volumes of buffer in order to obtain 0.5, 5, and 18 μM
final P450 concentration. The specific activity of the elec-
tron transfer components PdR and Pdx stayed constant at
0.4 U/mg total protein (corresponding to 3.2 U per μM
CYP154C5). As expected, the more enzyme present in
the reaction mixture the more substrate was converted
(Figure 2). At the same time the obtained TTN decreasedFigure 2 Steroid bioconversions with cell-free extract (CFE) of E. coli C
CYP154C5 concentrations. CFE reactions with different concentrations o
potassium phosphate buffer pH 7.4 at 30°C for 24 h. Sodium formate (15
U/mL) were used for cofactor regeneration (NADH, 50 μM). Substrates we
cyclodextrin in water.significantly with increasing enzyme concentration. Thus,
highest TTN were achieved when using only 0.5 μM
P450. However, the absolute amount of hydroxylated ster-
oid that can be produced at such low enzyme concentra-
tion is still low. Thus, for a preparative-scale reaction
where high product yields are aspired, application of a
higher P450 concentration would be preferred. Further-
more, the addition of more NADH and formate dehydro-
genase (FDH) for cofactor regeneration in the CFE
reactions did not increase conversion further (data not
shown). Thus, the cofactor regeneration system is not lim-
iting the performance of the P450 system in our reactions
with CFE even if high P450 concentrations are applied.43(DE3) (pIT2cyp154C5) (pACYCcamAB) employing different
f progesterone (3) and testosterone (5) were performed in 50 mM
0 mM) and formate dehydrogenase from Candida boidinii (FDH, 0.5
re added as stock solutions in 36% w/v hydroxypropyl-β-
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CYP154C5 using CFE (Figure 2) and those obtained in
whole-cell bioconversions (OD = 40) of all steroids apply-
ing 3 μM CYP154C5 (Figure 1), whole cells still outper-
form reactions with CFE. Similar product amounts could
be achieved in whole-cell reactions, although six times
lower P450 concentrations were used in comparison to
CFE reactions. Hence, also significantly higher TTN can
be obtained in whole-cell bioconversions (Additional file
1: Figure S3). Therefore, whole cells overexpressing the
three proteins (CYP154C5, Pdx and PdR) and directly
regenerating NADH within the E. coli metabolism proved
to be more efficient for the production of hydroxylated
steroids compared to CFE and were thus chosen for
preparative-scale reactions.
Steroid conversions on preparative scale: product
elucidation
After investigation of important parameters for steroid
bioconversion on analytical scale, best reaction condi-
tions for each steroid were chosen for scale-up. Thus, an
optical density of 40 and 2 mM substrate concentration
were chosen for the whole cell steroid bioconversions
at 30°C, except for substrates 3 and 5 where 4 and
1 mM were employed, respectively. In this way, suffi-
cient amounts of products could be prepared and puri-
fied by column chromatography. Afterwards, product
structures were elucidated by employing one- and two-
dimensional NMR techniques in order to determine the
regio- and stereoselectivity of CYP154C5 (see Additional
file 1). As a result, an exceptionally high regio- and
stereoselectivity was found for CYP154C5 in steroid
conversions of 1–6 always yielding the corresponding
16α-hydroxylated products (7–12, Figure 3). Only in the
case of androstenedione (4) and nandrolone (6), small
amounts of a secondary product were formed. However,
the amounts were so low that they could be easily re-
moved by column chromatography purification. As men-
tioned before, 16α-hydroxylation of testosterone (5) by
CYP154C5 had already been demonstrated by Agematu
et al. on analytical scale and was now confirmed for five
other steroid substrates by our NMR results [11].
Conversions and TTN achieved on preparative-scale
were similar to the results of the analytical-scale bio-
transformations. Hence, scale up did not negatively in-
fluence the performance of the whole-cell biocatalyst.
Substrates 1, 2, 3 and 4 were fully converted within
24 h of reaction whereas only one third and one half of
the initial substrate concentration of 5 and 6, respect-
ively, were hydroxylated under the applied reaction
conditions. Furthermore, isolated yields of the purified
steroid products without optimization of the purifica-
tion conditions ranged between 70-80% (40–130 mg
hydroxylated steroid).Reaction kinetics of the resting whole-cell system
In order to further characterize the performance of the
whole-cell system, turnover numbers (TON, μmol of sub-
strate consumed per min per μmol CYP154C5) for all
six steroid substrates were determined. In this way the
efficiency of the catalytic system for the different sub-
strates could be analyzed and compared. Bioconversions
using whole cells of E. coli C43(DE3) (pIT2cyp154C5)
(pACYCcamAB) were performed with an OD600 of 40
(corresponding to 3 μM CYP154C5) and 2 mM substrate
concentration. As shown in Figure 4, the substrate conver-
sion rate differs significantly depending on the applied
steroid. Substrates 1, 2, 3 and 4 reached full conversion
within the first 4–6 hours of reaction, whereas in biocon-
versions of 5 and 6 roughly only 50% of the substrate was
converted within the first 8 hours (Figure 4). This results
in space-time yields of the whole-cell system of 2.7, 3.0,
4.0, 3.6, 0.9 and 1.5 g L-1 d-1 for steroid products 7, 8, 9,
10, 11 and 12, respectively.
Surprisingly, the conversion of some steroids, espe-
cially pregnenolone (1), was rather low during the first
hour (Figure 4a). Thus, in order to determine the
highest rates of steroid conversion by the whole-cell
system, TON were calculated starting at two hours of
reaction (0 and 1 h data points were not included in
the calculation). As expected, 5 and 6 gave the lowest
TON, approximately 1 μmol of substrate was con-
sumed per minute per μmol of CYP154C5. In contrast,
1 and 3 gave a 3-fold higher TON in comparison to 5
and 6 (Table 1).
Discussion
Industrial steroid synthesis involves sophisticated chem-
ical and enzymatic steps including the selective incorp-
oration of hydroxyl groups in the steroid backbone. For
this reason, cytochrome P450 monooxygenases, which
are able to directly hydroxylate non-activated carbon
atoms, are attractive enzymes for the production of ster-
oid hormones in the pharmaceutical industry. In the
present paper, the recombinant expression and biocata-
lytic characterization of bacterial CYP154C5 for the
regio- and stereoselective hydroxylation of different ster-
oid compounds is reported. Since the natural electron
transfer partners of this P450 are unknown, Pdx and
PdR from P. putida were employed to supply CYP154C5
with the necessary electrons for catalysis. Using a two-
plasmid system, the three different proteins, CYP154C5,
Pdx and PdR, were coexpressed in soluble and active
form in E. coli yielding good levels of CYP154C5 (ap-
proximately 2% of total protein) and sufficient activity of
the electron transfer components (up to 1.4 U/mg of
total protein).
Applying this three-component system in bioconver-
sions of six different steroid substrates (1–6) we could
Figure 3 Bioconversion of steroids 1–6 by the three component system composed of CYP154C5, Pdx and PdR. Product structures (7–12)
were determined by one and two-dimensional NMR techniques.
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stereoselectivity not only for testosterone but also for all
other tested steroids always giving 16α-hydroxylated
products (7–12). Such a high specificity in the hydroxyl-
ation of various steroids carrying different functional
groups and differing in the position of double bonds is
remarkable since often more than one product is formed
for the same steroid substrate by a P450 monooxygenase
[6,11,19,20] and regioselectivities even vary with change
of the steroid substrate ([6,20] and unpublished results).Figure 4 Turnover number (TON) determination for whole cells of E.
biotransformations. TTN and conversion of a) pregnenolone (1) and b) p
bioconversions were carried out in 50 mM potassium phosphate buffer pH
regeneration. Substrates (2 mM) were added as stock solutions in 36% w/v
in triplicate.With CYP154C5 only in the case of 4 and 6 low quan-
tities of a secondary product were observed in whole-
cell transformations, which, however, were not formed
using purified proteins. Hence, they might not be direct
products of CYP154C5 catalysis. Steroid hydroxylation
in 16α-position was also described in literature for a
P450 monooxygenase from Streptomyces roseochromogenes
NCIB 10984 as well as CYP123 from Rhodococcus
erythropolis PR4 and CYP110A1 from Nostoc sp. PCC7120
[11,21]. However, reported steroid hydroxylation activitiescoli C43 (DE3) (pIT2cyp154C5) (pACYCcamAB) in steroid
rogesterone (3) and testosterone (5) over time are given. All
7.4 at 30°C with an OD600 of 40 and 30 mM glucose for cofactor
hydroxypropyl-β-cyclodextrin in water. Reactions were performed
Table 1 Calculated TON for whole-cell bioconversions of
E. coli C43(DE3) (pIT2cyp154C5) (pACYCcamAB) and six
different steroid substrates at 30°C
Substrate TON (μmol substrate consumed
min-1 μmol-1 CYP154C5)
Pregnenolone (1) 3.28 ± 0.05
Dehydroepinadrosterone (2) 2.90 ± 0.17
Progesterone (3) 3.33 ± 0.10
Androstenedione (4) 2.15 ± 0.03
Testosterone (5) 0.82 ± 0.01
Nandrolone (6) 1.24 ± 0.15
Values represent the mean of triplicate measurements.
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per hour per mmol P450 for the enzyme from S.
roseochromogenes) and further oxyfunctionalization of the
product at additional positions was reported. In con-
trast, the here obtained TON with CYP154C5 are
already by a factor of 40 to 160 higher depending on
the used steroid substrate.
Comparing the efficiency of steroid bioconversions
using either resting whole cells or cell-free extract of
E. coli C43(DE3) (pIT2cyp154C5) (pACYCcamAB)
clearly revealed an advantage of our whole-cell system,
especially at high initial substrate concentrations. Not
only significantly higher steroid concentrations (up to
15 mM) were still efficiently converted using whole cells,
also substantially higher TTN and product yields could
be achieved applying only low P450 concentrations.
Thus, space-time yields of several grams of hydroxylated
steroid per liter and day could be obtained. However,
when comparing both systems it has to be taken into ac-
count that in the case of CFE reactions (i) a different co-
factor regeneration system was used and (ii) the applied
ETC activity was slightly lower as compared to the
whole-cell system. Nevertheless we could prove that
NADH regeneration by formate dehydrogenase and so-
dium formate in the CFE system was not limiting the
overall performance of the P450 reaction. Furthermore,
similar product yields for both systems could only be
obtained using six times higher P450 concentration
and three times higher volumetric ETC activity in CFE
reactions as compared to whole cells. Thus, the slightly
lower ETC activity in CFE reactions alone cannot
account for the significantly reduced conversions and
product yields obtained with the CFE system as com-
pared to whole cells. Hence, the experimental results
clearly prove the superior performance of our whole-cell
system over reactions using CFE. In contrast, Zehentgruber
et al. [6] reported that the use of crude cell extract (CCE)
of recombinantly expressed CYP106A2 from Bacillus
megaterium in E. coli together with bovine adrenodoxinand adrenodoxin reductase as redox partners resulted in
significantly higher initial reaction rates as compared to
whole cells in testosterone and progesterone bioconver-
sions. However, the authors applied only low substrate con-
centrations (0.5 mM) since activity decreased significantly
at higher steroid concentrations. On the other hand, the se-
lectivity of their P450 system decreased to 80% when using
CCE in comparison to whole cells due to unwanted forma-
tion of secondary hydroxylation products.
In literature, generally only low initial steroid concen-
trations (<1 mM) are applied in biotransformations of
steroids using bacterial or eukaryotic P450 systems
(whole-cell as well as isolated enzyme approaches). This
might be explained by the very low solubility of steroids
in aqueous solution [22], typically low rates of the ap-
plied P450s or the possible inhibitory (or even toxic) ef-
fect of steroids for microbial cells and enzymes. The low
solubility of steroids is usually overcome by the use of a
co-solvent such as methanol. Furthermore, the use of
hydroxypropyl-β-cyclodextrin for the solubilization of
steroids in aqueous solution was also reported [23-26].
Thereby, the cyclodextrin derivative offers the advantage
that even high steroid concentrations are efficiently
dissolved in the aqueous reaction media. In contrast,
comparably high amounts of methanol, exhibiting a de-
stabilizing effect on enzymes and cells, would be neces-
sary to achieve the same. For potential industrial
applications productivities of several grams per liter are
required [8], emphasizing the need for biocatalytic sys-
tems that efficiently hydroxylate large steroid amounts
with good rates and thus achieve high product titers.
Our E. coli-based whole-cell biocatalyst containing
CYP154C5, Pdx and PdR still efficiently hydroxylated
steroids at concentrations of 4 mM or higher. Thus, pro-
ductivities of 2–3 g/L could be achieved in case of preg-
nenolone (1), dehydroepiandrosterone (2), progesterone
(3) and androstenedione (4). The use of hydroxypropyl-
β-cyclodextrin in our reactions clearly facilitated the
solubilization and thus conversion of the required ster-
oid amounts without exhibiting any destabilizing effects
on cells or enzymes. Only for testosterone (5) and nan-
drolone (6) much lower yields were obtained at initial
steroid concentrations of 1 mM or higher. Likewise also
the measured TON for the two steroids using our
whole-cell system are by a factor of 2–3 lower compared
to the other steroids. This might be due to a different
substrate specificity of the enzyme or even an inhibitory
effect of the two steroids at higher concentrations. Struc-
turally, testosterone (5) and nandrolone (6) are very
similar, both carrying a hydroxyl group at carbon 17,
which might explain the similar behavior. Currently we
are trying to solve the crystal structure of CYP154C5 in
order to reveal structural determinants of the enzyme’s
high regio- and stereoselectivity in steroid hydroxylation
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reactivity of CYP154C5 towards the different steroids.
Conclusion
Bacterial CYP154C5 from N. farcinica constitutes a
promising catalyst due to its high regio- and stereo-
selectivity in the hydroxylation of various pregnanes
and androstanes as well as its high-level expression in
E. coli. Using this enzyme, 16α-hydroxylated steroids,
which are important precursors in the synthesis of high
value steroidal drugs such as glucocorticoids in the
pharmaceutical industry, can be produced. Furthermore,
an E. coli-based whole-cell biocatalyst – recombinantly ex-
pressing CYP154C5 together with putidaredoxin and
putidaredoxin reductase as redox partners – was gener-
ated that allowed efficient conversion of the different ster-
oid substrates even at high initial steroid concentration
with the sole addition of glucose for cofactor regeneration.
Methods
Chemicals
Pregnenolone, testosterone, progesterone and choles-




stenedione were purchased from Steraloids Inc., USA. All
solvents and chemicals necessary for the experiments were
obtained from Applichem, Roth or Sigma-Aldrich and used
without further purification.
Bacterial strains and plasmids
The Escherichia coli TOP10 strain (Invitrogen, Carlsbad,
CA, USA) was used for genetic manipulations, while
E. coli C43(DE3) (Lucigen, Middleton, WI, USA) was
used for expressions.
Plasmid pACYC-Duet1 was purchased from Novagen
(EMD Biosciences, San Diego, CA, USA) while the broad
host-range expression vector pIT2-MCS was prepared
as described elsewhere [16]. Plasmid pKNL031_M17 from
a genomic library of Nocardia farcinica containing the
gene of CYP154C5 (nfa53110, GenBank: NC_006361) was
kindly provided by Jun Ishikawa (National Institute
of Infectious Diseases, Japan). Preparation of plasmid
pACYCcamAB for coexpression of putidaredoxin re-
ductase (CamA) and putidaredoxin (CamB) from
Pseudomonas putida was described elsewhere [16].
Cloning of cyp154C5 from N. farcinica
The gene of CYP154C5 was amplified by PCR from vector
pKNL031_M17 using primers NF-P-NdeI-FW: 5′-AA
AAAAAACATATGAACGCCTGCCCCCATTCGG-3′ and
NF-P-HindIII-RV: 5′-TTTTTTAAGCTTCACCTGCCCA
GGTGGATGGG-3′. Thereby restriction sites NdeI andHindIII were introduced for subsequent cloning of
cyp154C5 into vector pIT2-MCS. The resulting vector was
named pIT2cyp154C5.
Expression of Escherichia coli C43(DE3) (pIT2cyp154C5)
(pACYCcamAB)
E. coli C43(DE3) (pIT2cyp154C5) (pACYCcamAB) was
used for coexpression of CYP154C5 together with CamA
and CamB in one host. For that, 5 mL liquid LB media
supplemented with tetracycline (10 μg/mL final concen-
tration) and chloramphenicol (25 μg/mL final conc.) was
inoculated from a frozen stock of E. coli C43(DE3)
(pIT2cyp154C5) (pACYCcamAB). After overnight incu-
bation at 37°C and 250 rpm, a 200 mL TB preculture
supplemented with tetracycline (10 μg/mL) and chlor-
amphenicol (25 μg/mL) was inoculated with 1% v/v of
the overnight culture and incubated for 24 h under the
same conditions. Finally, a 16 L fermentor containing
9.8 L of TB media supplemented with tetracycline
(10 μg/mL), chloramphenicol (25 μg/mL) and 0.1% v/v
trace element solution (0.50 g/L of CaCl2*2H2O, 0.18 g/L
of ZnSO4*7H2O, 0.10 g/L of MnSO4*H2O, 20.10 g/L of
Na2-EDTA, 16.70 g/L of FeCl3*6H2O, 0.16 g/L of
CuSO4*5H2O and 0.18 g/L of CoCl2*6H2O) was inocu-
lated with 2% v/v preculture. The pH was set to 7.0 and
adjusted during the expression with 5 M KOH and H3PO4
solutions. Dissolved oxygen was controlled with a pO2
electrode. Foam formation was controlled using commer-
cial Antifoam from Sigma. At an optical density (OD600)
of 1 the system was induced with isopropyl-β-D-1-thio-
galactopyranoside (IPTG, 200 μg/mL final conc.) and δ-
aminolevulinic acid (84 μg/mL final conc.) was added as a
precursor for heme synthesis. After 24 hours of expression
at 30°C and 300 rpm the cells were harvested by centrifuga-
tion (4424 x g, 4°C for 15 min), washed with 50 mM potas-
sium phosphate buffer pH 7.4, centrifuged again (4424 × g,
4°C for 15 min) and the pellets were stored at −20°C.
E. coli C43(DE3) (pACYCcamAB) harbouring the
camA and camB gene but not the gene of CYP154C5
was used as control strain in bioconversions. In this
case, expression was performed according to the proced-
ure described for E. coli C43(DE3) (pIT2cyp154C5)
(pACYCcamAB) in 500 mL scale with 2 modifications:
only chloramphenicol (25 μg/mL) was used for selective
growth and δ-aminolevulinic acid was not added during
the expression.
Enzyme assays
All assays were measured with cell lysate of E. coli
C43(DE3) (pIT2cyp154C5) (pACYCcamAB) or E. coli
C43(DE3) (pACYCcamAB). Thus, frozen cells were
resuspended in 50 mM potassium phosphate buffer
pH 7.4 in order to reach an optical density of 40 and
phenylmethylsulfonyl fluoride (17 μg/mL final conc.)
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performed in an EmulsiFlex-Homogenizer (Avestin,
Germany) with 5 cycles of 1500 psi. After centrifugation
(17,696 x g, 4°C for 45 min) the resulting CFE was im-
mediately used for the assays. CYP154C5 concentration
was measured by CO-difference spectra [27] and calcu-
lated based on the maximum absorbance of CO-bound
CYP154C5 at 450 nm (ε450=91 mM
-1 cm-1). The activity
of the electron transfer components (ETC) Pdx and PdR
in CFE was determined by the cytochrome c reduction
assay [28], monitoring the increase in absorbance at
550 nm (ε550=19.1 mM
-1 cm-1).
Analytical scale bioconversions
In case of whole-cell bioconversions, frozen cells of E. coli
C43(DE3) (pIT2cyp154C5) (pACYCcamAB) overexpressing
Pdx, PdR and CYP154C5 were resuspended in 50 mM po-
tassium phosphate buffer pH 7.4 to the desired final OD600.
All bioconversions were carried out in 1 mL scale at 30°C
and 250 rpm with addition of glucose (0.54 mg/mL final
conc.) for cofactor regeneration within the E. coli metabol-
ism. Substrate stock solutions of steroids were prepared in
36% w/v hydroxypropyl-β-cyclodextrin in water. For sub-
strates 3–6, stocks of 100 mM were prepared whereas only
50 mM stocks could be used for substrates 1 and 2. From
the prepared stocks, the respective amounts were added to
the reactions in order to achieve final steroid concentra-
tions of 0.5 to 15 mM. Hence, the ratio between substrate
and hydroxypropyl-β-cyclodextrin stayed constant in each
reaction. Control reactions were carried out in parallel with
E. coli C43(DE3) (pACYCcamAB) which contained only
Pdx and PdR. After 20 hours of reaction the bioconversions
and controls were extracted for subsequent HPLC and GC
analysis. For that, the complete sample was extracted twice
with ethyl acetate (700 μL and 500 μL) and once with
chloroform (500 μL), the organic phases were combined,
dried with sodium sulfate and the solvent was removed
under reduced pressure.
In case of bioconversions using cell-free extract
(CFE), frozen cells of E. coli C43(DE3) (pIT2cyp154C5)
(pACYCcamAB) were resuspended in 50 mM potassium
phosphate buffer pH 7.4 and phenylmethylsulfonyl fluoride
(17 μg/mL final conc.) was added as protease inhibitor. Cell
disruption was performed in an EmulsiFlex-Homogenizer
(Avestin, Germany) with 5 cycles of 1500 psi. After centri-
fugation (17,696 x g, 4°C for 45 min) the resulting CFE was
immediately used for bioconversions. In 1 mL scale biocon-
versions, NADH (36 μg/mL final conc.) was used as elec-
tron donor, sodium formate (10 mg/mL final conc.) and
formate dehydrogenase from Candida boidinii (Sigma Al-
drich, 0.5 U/mL final activity) were added as NADH regen-
eration system in biocatalyses. Steroid substrates were also
added as stock solutions in 36% w/v hydroxypropyl-
β-cyclodextrin in water as described for whole-cellreactions. After 24 hours of reaction at 30°C and 250 rpm,
the bioconversions and controls were extracted as de-
scribed for the whole-cell system.
Preparative scale bioconversions and product purification
Preparative-scale bioconversions were carried out in
100–200 ml of 50 mM potassium phosphate buffer
pH 7.4 using resting whole cells of E. coli C43(DE3)
(pIT2cyp154C5) (pACYCcamAB) (from frozen stock) at
30°C and 250 rpm, with the addition of glucose
(0.54 mg/mL) in shake flasks. In all cases, resting cells
with an optical density of 40 were used which is equiva-
lent to approximately 3 μM CYP154C5 and an ETC ac-
tivity of 1.1 U/mg of total protein, as determined by CO-
difference spectra and cytochrome c assay, respectively.
Substrate stock solutions were prepared in 36% w/v
hydroxypropyl-β-cyclodextrin in water. In general 2 mM
substrate concentration was used, except for progester-
one (3) and testosterone (5) where 4 and 1 mM were
applied, respectively. After 22–24 h of reaction, the
complete reaction volume was extracted twice with ethyl
acetate (50 and 40 mL) and once with chloroform
(30 mL), the organic phases were combined, dried with
sodium sulfate and the solvent removed under reduced
pressure. Hydroxylated steroid products were afterwards
purified by silica gel column chromatography (silica gel
60; 0.2-0.5 mm; Roth) with a gradient of ethyl acetate in
n-heptane to pure ethyl acetate (starting with ethyl acet-
ate / n-heptane ratios of 6:4 for pregnenolone (1), 4:6 for
dehydroepiandrosterone (2), 9:1 for progesterone (3)
and testosterone (5), 7:3 for androstenedione (4) and
95:5 for nandrolone (6)) as mobile phase.
Turnover numbers
Frozen cells of E. coli C43(DE3) (pIT2cyp154C5)
(pACYCcamAB) were resuspended in 50 mM potas-
sium phosphate buffer pH 7.4 to an optical density
(OD600) of 40. This cell density was equivalent to a
P450 concentration of 3 μM and a specific activity of
the ETC of 0.7 U/mg of total protein, as determined by
CO-difference spectra and cytochrome c assay, respect-
ively. All bioconversions were carried out at 25 mL
scale in shake flasks for 26 h at 30°C and 250 rpm with
addition of 30 mM glucose for cofactor regeneration.
Substrate stock solutions were prepared in 36% w/v
hydroxypropyl-β-cyclodextrin in water. In all cases
2 mM initial steroid concentration was used. During
bioconversions, samples were taken every hour for sub-
sequent HPLC or GC analysis. For that, 1 mL of reac-
tion was extracted and the sample prepared for HPLC
or GC analysis as previously described. Turnover num-
bers were calculated based on substrate consumption
and for the period of time where the highest substrate
consumption rate was observed (generally between 60
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one (5) and nandrolone (6) were the period between
180 and 360 minutes was used). All bioconversions
were done in triplicate.
GC, GC-MS, HPLC and NMR analyses
In the case of pregnenolone (1) and dehydroepiandros-
terone (2) the solid residues were redissolved in chloro-
form containing 30 mM cholesterol as internal standard.
The samples were analyzed on a GC2010 gas chromato-
graph (Shimadzu) equipped with an OPTIMA 17ms
column (Macherey-Nagel, Germany) with a linear gradi-
ent starting at 250°C and heating with 10°C/min until
300°C. Injector and detector temperature were set to
350 and 300°C respectively. Substrates and products
were detected by FID. Both substrates, pregnenolone (1)
and dehydroepiandrosterone (2), eluted at a retention
time of 9.69 min and 7.94 min respectively, whereas
their products eluted at 9.27 (7) and 10.18 min (8)
respectively.
The dried residues of bioconversions with progesterone
(3), androstenedione (4), testosterone (5) and nandrolone
(6) were dissolved in acetonitrile: water (60:40) and
injected on a high performance liquid chromatograph
(HPLC, Beckmann Coulter) equipped with a Nucleosil
100–5 C18, 250 x 4,5 mm column (CS Chromatography
Service, Germany) at 50°C. Acetonitrile: water (60:40) was
used as mobile phase with a flow rate of 1 mL/min. Detec-
tion of substrates and their respective products was
performed by UV absorbance at 254 (5 and 11), 230 (3
and 9) and 245 nm (4, 6, 10 and 12). The substrates eluted
at 9.42 (3), 6.68 (4), 7.73 (5), and 5.93 (6) min, whereas the
main products were detected at 4.95 (9), 4.47 (10), 4.12
(11), and 3.95 (12) min. Secondary products of andro-
stenedione (4) and nandrolone (6) eluted at 5.68 and
5.22 min, respectively. In all cases conversions were calcu-
lated based on substrate consumption.
Preliminary product identification was performed
with a gas chromatograph - mass spectrometer (GC-
MS-QP2010S, Shimadzu, Germany) equipped with an
OPTIMA 17ms (products 8, 9, 11 and 12) or Supreme
5ms (products 7 and 10) column (Macherey-Nagel,
Germany) with a linear gradient starting at 250°C and
heating with 10°C/min until 300°C. Injector and inter-
face temperature were set to 300°C. For products 7, 10
and 11, derivatization using N-methyl-N-(trimethylsilyl)
trifluoroacetamide (MSTFA activated I, Sigma-Aldrich)
was necessary in order to facilitate GC-MS analysis.
Structure elucidation of formed products (7–11) was
performed by 1H, 13C, COSY and HSQC NMR analysis
on a Bruker AV400 instrument (1H-NMR 400 MHz and
13C-NMR 100 MHz). Measurement of product standards
and structure elucidation of product 12 was performed
by 1H, 13C, COSY, HSQC and NOESY NMR on a BrukerAV600 (1H-NMR 600 MHz and 13C-NMR 150 MHz). In
all cases deuterated chloroform was used as solvent with
TMS as internal standard except for product 7 were
deuterated DMSO with TMS was used. Chemical shifts
(δ) are given in ppm and coupling constant (J) in Hz
(see Additional file 1).
Additional file
Additional file 1: Figure S1. Representative HPLC chromatograms of
steroid bioconversions using E. coli C43(DE3) (pIT2cyp154C5)
(pACYCcamAB) and E. coli C43(DE3) (pACYCcamAB) as control. Figure S2.
Comparison of whole cells (WC) and cell-free extract (CFE) of E. coli C43
(DE3) (pIT2cyp154C5) (pACYCcamAB) in steroid bioconversions each
containing 3 μM CYP154C5; Figure S3. Comparison of TTN achieved in
steroid bioconversions by E. coli C43(DE3) (pIT2cyp154C5) (pACYCcamAB)
using cell-free extract containing 18 μM CYP154C5 and whole cells
containing 3 μM CYP154C5 (OD600 = 40). Furthermore, a detailed
description of product structure elucidation by GC-MS and NMR analysis
is given.
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